Search

Search Results
Results 5861 - 5870 of 5870 for Mental illness
  • Synacthen Depot
    Drug - 6 Aug 2020
    Consumer Medicine Information (CMI) about Synacthen Depot (tetracosactide) intended for persons living in Australia.
  • Riamet
    Drug - 22 Jul 2020
    Consumer Medicine Information (CMI) about Riamet (Artemether and lumefantrine) intended for persons living in Australia.
  • Riamet Dispersible Tablets
    Drug - 22 Jul 2020
    Consumer Medicine Information (CMI) about Riamet Dispersible Tablets (artemether and lumefantrine) intended for persons living in Australia.
  • Synacthen
    Drug - 22 Jun 2020
    Consumer Medicine Information (CMI) about Synacthen (tetracosactide) intended for persons living in Australia.
  • Minims Atropine Sulphate
    Drug - 1 May 2020
    Consumer Medicine Information (CMI) about Minims Atropine Sulphate (Atropine sulfate monohydrate) intended for persons living in Australia.
  • Minidiab
    Drug - 9 Dec 2019
    Consumer Medicine Information (CMI) about Minidiab (Glipizide) intended for persons living in Australia.
  • Micardis® (Telmisartan) Consumer Medicine Information
    Drug - 20 Jun 2019
     
  • Daonil
    Drug - 1 Sep 2016
    Consumer Medicine Information (CMI) about Daonil (glibenclamide) intended for persons living in Australia.
  • Glucovance
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Glucovance intended for persons living in Australia.
  • Karuna Therapeutics
    Supplier - 1 Jun 2023
    Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback